| Characteristics | Anemic | Not anemic | Total | P Value | ||
| M0 | M6 | |||||
| Age | 22 - 35 years | 7 (50%) | 7 (50%) | 14 (100.0) | 0.98 | 1.00 |
| 36 - 45 years | 7 (53.8%) | 6 (46.2%) | 13 (100.0) | |||
| 45 years and over | 4 (57.1%) | 3 (42.9%) | 7 (100.0) | |||
| IO | ≤1 IO | 3 (42.86%) | 4 (57.14%) | 7 (100.0) | 0.05 | 0.69 |
| 2 - 3 IO | 5 (62.5) | 3 (37.7%) | 8 (100.0) | |||
| WHO stages | Stage I | 10 (52.6%) | 9 (47.4%) | 19 (100.0) | 0.01 | 0.47 |
| Stage II | 2 (40.0%) | 3 (60.0%) | 5 (100.0) | |||
| Stage III | 3 (42.9%) | 4 (57.1%) | 7 (100.0) | |||
| Stage IV | 3 (100.0%) | 0 (0.0%) | 3 (100.0) | |||
| Viral load | ≤100,000 copies | 8 (33.3%) | 16 (66.7%) | 24 (100) | 0.08 | 0.71 |
| >100,000 copies | 5 (50.0%) | 5 (50.0%) | 10 (100.0) | |||
| CD4 count | ≤500 | 12 (48.0%) | 13 (52.0% | 25 (100.0) | 0.01 | 0.68 |
| >500 | 5 (62.5%) | 3 (37.5%) | 8 (100.0) | |||